Which laboratory finding is most associated with an increased risk of leiomyoma?

Mild anemia is often associated with an increased risk of leiomyoma, commonly known as uterine fibroids. Leiomyomas can lead to menorrhagia (excessive menstrual bleeding), which may subsequently result in anemia due to chronic blood loss. As women with leiomyomas experience heavy menstrual periods, they may develop mild anemia characterized by lower-than-normal hemoglobin levels. The presence of anemia can thus be a clinical indicator suggesting a potential underlying fibroid pathology, particularly in women presenting with typical symptoms like heavy menstrual bleeding.

In contrast, thrombocytopenia, increased white blood cell count, and baseline hyperemia do not have a direct association with the risk of developing leiomyomas. Thrombocytopenia typically indicates bone marrow issues or systemic conditions, while an elevated white blood cell count often signals infection or inflammation. Baseline hyperemia may refer to increased blood flow to a region, but it doesn't specifically correlate with the development of leiomyomas. Therefore, the connection between mild anemia and the presence of uterine fibroids makes it the most relevant finding in this context.